Imeglimin

CAS Number: 775351-65-0

Molecular Formula: C6H13N5

Purity: Imeglimin 98% purity

About Imeglimin

Imeglimin (CAS 847925-91-1) represents a breakthrough in the API intermediates market as the first-in-class oxidative phosphorylation blocker for treating type 2 diabetes, driving significant demand for high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) that can support its unique mitochon...

Synonyms

imeglimin
Imeglimin
775351-65-0
Imeglimin [INN]
Emd 387008 hcl

View all

Imeglimin Specifications

CAS Number

775351-65-0

Molecular Formula

C6H13N5

Molecular Weight

155.21 g/mol

IUPAC Name

(4R)-6-N,6-N,4-trimethyl-1,4-dihydro-1,3,5-triazine-2,6-diamine

Canonical SMILES

CC1N=C(NC(=N1)N(C)C)N

InChI Key

GFICWFZTBXUVIG-SCSAIBSYSA-N

InChI

InChI=1S/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m1/s1

HSN No

29335990

CAS Number

775351-65-0

Molecular Formula

C6H13N5

Molecular Weight

155.21 g/mol

IUPAC Name

(4R)-6-N,6-N,4-trimethyl-1,4-dihydro-1,3,5-triazine-2,6-diamine

Canonical SMILES

CC1N=C(NC(=N1)N(C)C)N

InChI Key

GFICWFZTBXUVIG-SCSAIBSYSA-N

InChI

InChI=1S/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m1/s1

HSN No

29335990

Molecular Weight

155.21 g/mol

Purity

Imeglimin 98% purity

Antidiabetic Agent

A novel, first-in-class oral hypoglycemic medication belonging to the glimin class, used primarily for the management of type 2 diabetes mellitus by targeting mitochondrial bioenergetics to enhance glucose-stimulated insulin secretion, improve insulin sensitivity, and inhibit hepatic gluconeogenesis

Pharmaceutical Intermediate

A specialized chemical building block utilized in the synthesis of tetrahydrotriazine-containing compounds and advanced metabolic disorder therapies

Research Tool

A critical small molecule employed in life science research to study mitochondrial respiratory chain modulation, oxidative stress reduction, and cellular energy metabolism pathways.